<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1682-0037</journal-id>
<journal-title><![CDATA[Revista Cubana de Angiología y Cirugía Vascular]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Angiol Cir Vasc]]></abbrev-journal-title>
<issn>1682-0037</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1682-00372020000200008</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización de la enfermedad estenooclusiva aortoiliaca]]></article-title>
<article-title xml:lang="en"><![CDATA[Characterization of the stenocclusive aortoiliac disease]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Rodríguez]]></surname>
<given-names><![CDATA[Yasser]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Mayoral]]></surname>
<given-names><![CDATA[Jorge Augusto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Universitario &#8220;General Calixto García Iñiguez&#8221;  ]]></institution>
<addr-line><![CDATA[La Habana ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<volume>21</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1682-00372020000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1682-00372020000200008&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1682-00372020000200008&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción:  La enfermedad arterial periférica, específicamente del sector aortoiliaco, es multifactorial, tiene como causa principal la ateroesclerosis obliterante. Las manifestaciones clínicas son variables y la claudicación intermitente es la más frecuente, por lo que es subdiagnosticada.  Objetivo:  Caracterizar los pacientes con enfermedad estenoclusiva aortoiliaca  Métodos:  Estudio observacional descriptivo retrospectivo de corte transversal en 86 pacientes ingresados mayores de 18 años de edad con enfermedad estenoclusiva aortoiliaca. Las variables incluidas fueron: edad, sexo, factores de riesgo, clasificación de Fontaine, índice de presiones, patrón por angiografía, conducta, tipos de cirugía vascular, complicaciones, evolución, letalidad quirúrgica global. Fueron atendidos en el hospital Universitario &#8220;Calixto García Iñiguez&#8221; entre los años 2015 y 2018.  Resultados:  Se encontró que 72 % de los pacientes era mayor de 60 años y 67,4 % eran hombres. Los factores de riesgo más frecuentes fueron el tabaquismo (73,9 %) y la hipertensión arterial (74,4 %); 34,8 % presentó dolor en reposo y 41,8 % lesiones. El 83,8 % tuvo un índice tobillo brazo menor o igual a 0,4. El 52,4 % clasificó en Darling tipo III. Se revascularizaron 27 casos y 44,2 % tuvo una amputación primaria. Se complicaron 27,6 % y la evolución fue favorable en 54,7 %. La letalidad quirúrgica global fue de 3,03 %.  Conclusiones:  Se observó que los hombres mayores de 60 años con factores de riesgos eran más propensos a padecer una enfermedad arterial periférica. Se obtuvo una evolución favorable en la mayoría de los casos con un bajo índice de letalidad quirúrgica global.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Peripheral arterial disease, specifically in the aortoiliac sector, is multifactorial. It has as main cause the obliterating atheroesclerosis, and the clinical manifestations are changeable and the intermittent claudication is the most frequent, that is why it is underdiagnosed.  Objective:  To characterize the patients with stenocclusive aortoiliac disease.  Methods:  Descriptive observational, retrospective and cross-sectional study in 86 patients admitted in hospital, all of them over 18 years old with stenocclusive aortoiliac disease. The variables included were: age, sex, risk factors, Fontaine classification, index of pressures, angiography pattern, behaviour, types of vascular surgery, complications, evolution, and overall surgical lethality. The patients were attended in &#8220;Calixto García Iñiguez&#8221; University Hospital from 2015 to 2018.  Results:  It was found that 72.0% of the patients were older than 60 years and the 67.4% were men. The most frequent risk factors were the smoking habit (73.9%) and hypertension (74.4%); 34.8% presented pain in rest and 41.8% presented lesions. The 83.8% had an anklebrachial index lower or equal to 0.4. The 52.4% classified as Darling type III. There were 27 patients under revascularization and 44.2% had a primary amputation. The 27.6% of the cases had complications and the evolution was favourable in the 54.7%. The overall surgical lethality was of 3.03%.  Conclusions:  It is observed that men over 60 years old with risk factors were proner to suffer from peripheral arterial disease. It was achieved a favourable evolution in most of the cases with a low index of overall surgical lethality.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[enfermedad estenoclusiva]]></kwd>
<kwd lng="es"><![CDATA[aortoiliaca]]></kwd>
<kwd lng="es"><![CDATA[enfermedad arterial periférica]]></kwd>
<kwd lng="en"><![CDATA[stenocclusive disease]]></kwd>
<kwd lng="en"><![CDATA[aortoiliac]]></kwd>
<kwd lng="en"><![CDATA[peripheral arterial disease]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinella Portuondo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínica de pacientes portadores de enfermedad vascular periférica complicada]]></article-title>
<source><![CDATA[Rev Cubana Med]]></source>
<year>2018</year>
<volume>47</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>36-46</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fernández Travieso]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad arterial periférica en adultos mayores]]></article-title>
<source><![CDATA[Rev CNIC]]></source>
<year>2013</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>43-62</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menard]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Sk]]></surname>
<given-names><![CDATA[Shah]]></given-names>
</name>
<name>
<surname><![CDATA[Belkin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aortoiliacd: Direct reconstruction]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Sidawy]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Perler]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<source><![CDATA[Rutherford's Vascular Surgery and Endovascular Therapy]]></source>
<year>2019</year>
<edition>9th</edition>
<page-range>1398-414</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suárez Fernández]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lozano Sánchez]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[Bellmunt]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Camafort]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mancera]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Documento de consenso multidisciplinar en torno a la enfermedad arterial periférica]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Luzán 5, S.A.]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alcocer]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Fanghanel]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estratificación del riesgo cardiovascular global Comparación de los métodos Framingham y score en población mexicana del estudio PRIT]]></article-title>
<source><![CDATA[Cir Cir]]></source>
<year>2011</year>
<volume>79</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-74</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conte]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Bradbury]]></surname>
<given-names><![CDATA[AW]]></given-names>
</name>
<name>
<surname><![CDATA[Kolh]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[JV]]></given-names>
</name>
<name>
<surname><![CDATA[Dick]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Fitridge]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Global vascular guidelines on the management of chronic limb-threatening ischemia]]></article-title>
<source><![CDATA[J Vasc Surg]]></source>
<year>2019</year>
<numero>19</numero>
<issue>19</issue>
<page-range>30992-9</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallardo Pérez]]></surname>
<given-names><![CDATA[UJ]]></given-names>
</name>
<name>
<surname><![CDATA[Seuc Jo]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Chirino Carreño]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Puentes Madera]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mortalidad por enfermedades vasculares periféricas en Cuba en el año 2005]]></article-title>
<source><![CDATA[Rev Cubana Invest Bioméd]]></source>
<year>2008</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Púbica</collab>
<source><![CDATA[Estadísticas de Salud en Cuba. Anuario Estadístico 2018]]></source>
<year>2018</year>
<publisher-loc><![CDATA[La Habana Cuba ]]></publisher-loc>
<publisher-name><![CDATA[Dirección de Registros Médicos y Estadísticas de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Libby]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Bornfeldt]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Tall]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Atherosclerosis Successes, surprises, and future challenges]]></article-title>
<source><![CDATA[Circ Res]]></source>
<year>2016</year>
<volume>118</volume>
<page-range>531-4</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>Pérez de Isla L.Álvarez-Sala L.Barrios Alonso WV.Castro Conde A.Galve Basilio E.García Ortiz L</collab>
<article-title xml:lang=""><![CDATA[Comentarios a la guía ESC/EAS 2016 sobre el tratamiento de las dislipemias]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2017</year>
<volume>70</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>72-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Terentes-Printzios]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiovascular risk factors accelerate progression of vascular aging in the general population Results from the CRAVE Study (Cardiovascular Risk Factors Affecting Vascular Age)]]></article-title>
<collab>Vlachopoulos Ch</collab>
<source><![CDATA[Hypertension]]></source>
<year>2017</year>
<volume>70</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1057-64</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Tabaco]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>World Health Organizatión</collab>
<source><![CDATA[World health statistics 2018: monitoring health for the SDGs, sustainable development goals]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Diabetes]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>American Diabetes Association (ADA)</collab>
<source><![CDATA[Datos sobre la diabetes]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Washington, D. C. ]]></publisher-loc>
<publisher-name><![CDATA[ADA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Información general sobre la hipertensión en el mundo]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aboyans]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ricco]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guía ESC 2017 sobre el diagnóstico y tratamiento de la enfermedad arterial periférica, desarrollada en colaboración con la European Society for Vascular Surgery (ESVS)]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2018</year>
<volume>71</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111.e1-e69</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad oclusiva aortoilíaca o síndrome de Leriche]]></article-title>
<source><![CDATA[Rev Colomb Cir]]></source>
<year>2008</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>214-22</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz Limonta]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez de la Guardia]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chércoles Cazate]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínica y quirúrgica de pacientes con enfermedad arterial periférica aortoilíaca]]></article-title>
<source><![CDATA[Medisan]]></source>
<year>2013</year>
<volume>17</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>3049-59</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Talledo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Valdez]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad oclusiva aorto-iliaca: Del tratamiento quirúrgico al endovascular]]></article-title>
<source><![CDATA[Rev Med Hered]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>177-85</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prieto Valdés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación del tratamiento endovascular de las lesiones obliterantes del sector aortoilíaco]]></article-title>
<source><![CDATA[Invest Medicoquir]]></source>
<year>2014</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-35</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Deibler]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Erling Jr]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamento cirúrgico da oclusão crônica aorto-ilíaca]]></article-title>
<source><![CDATA[J Vasc Bras]]></source>
<year>2015</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-36</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rabellino]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chas]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lucas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento endovascular en oclusiones aortoilíacas]]></article-title>
<source><![CDATA[Rev Argent Cardiol]]></source>
<year>2016</year>
<volume>84</volume>
<page-range>250-3</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mantilla Acosta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fleitas Pérez]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ibarra López]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Derivación aorto-bi-femoral. Presentación de caso]]></article-title>
<source><![CDATA[Mediciego]]></source>
<year>2016</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández Seara]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cabrera Zamora]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Viña Cisneros]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de los pacientes ingresados por isquemia crítica de los miembros inferiores]]></article-title>
<source><![CDATA[Rev Cubana Angiol Cir Vasc]]></source>
<year>2013</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-22</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flu]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Lardenoye]]></surname>
<given-names><![CDATA[JHP]]></given-names>
</name>
<name>
<surname><![CDATA[Veen]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Aquarius]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[van Berge Hene]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morbilidad y mortalidad secundaria a complicaciones cardiológicas después de la revascularización de extremidad por isquemia crítica]]></article-title>
<source><![CDATA[An Cir Vasc]]></source>
<year>2009</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>642-57</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
